Approval · Notice of Compliance 12475 · 2011
MEGACE OS: Notice of Compliance 12475
Issued June 30, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12475
- Date
- June 30, 2011
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of progestogen and antineoplatic indications due to the discontinuation of tablet presentation from the Product Monograph
- Therapeutic class
- Antianorexic, Anticachectic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEGACE OS | Not yet assigned | — |
Medicinal ingredients
- MEGESTROL ACETATE 40 MG per ML